Compare CPAY & LH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CPAY | LH |
|---|---|---|
| Founded | 1986 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.8B | 22.1B |
| IPO Year | 2010 | N/A |
| Metric | CPAY | LH |
|---|---|---|
| Price | $299.84 | $266.22 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 13 |
| Target Price | ★ $375.09 | $299.00 |
| AVG Volume (30 Days) | 622.2K | ★ 970.9K |
| Earning Date | 11-05-2025 | 10-28-2025 |
| Dividend Yield | N/A | ★ 1.08% |
| EPS Growth | 5.04 | ★ 98.36 |
| EPS | ★ 14.72 | 10.19 |
| Revenue | $4,314,608,000.00 | ★ $13,765,300,000.00 |
| Revenue This Year | $15.86 | $10.82 |
| Revenue Next Year | $15.55 | $4.44 |
| P/E Ratio | ★ $20.36 | $26.09 |
| Revenue Growth | ★ 11.27 | 8.28 |
| 52 Week Low | $252.84 | $209.38 |
| 52 Week High | $400.81 | $293.72 |
| Indicator | CPAY | LH |
|---|---|---|
| Relative Strength Index (RSI) | 63.47 | 49.63 |
| Support Level | $292.03 | $264.66 |
| Resistance Level | $299.70 | $272.82 |
| Average True Range (ATR) | 6.87 | 5.01 |
| MACD | 2.48 | 0.90 |
| Stochastic Oscillator | 97.96 | 52.48 |
Corpay Inc is a corporate payments company that helps businesses and consumers manage and pay their expenses. Its suite of modern payment solutions helps customers manage vehicle-related expenses, lodging expenses, and corporate payments. Its reportable segments are; Vehicle Payments, Corporate Payments, Lodging Payments, and Other. The group's geographic areas are the United States, Brazil, the United Kingdom, and Other.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.